Catherine Bollard

CABA

Catherine Bollard serves as Director at Cabaletta Bio, Inc. (CABA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$21.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$21.0K

Companies Traded

CABA

Active Period

Oct 2022 – Jan 2026

2 total trades

Most Recent

Buy CABA

Jan 21, 2026 · $20.0K

Catherine Bollard's Insider Trading at Cabaletta Bio, Inc. (CABA)

Buys

2 · $21.0K

Sells

0 · $0.00

Total Shares Bought

9,810

Total Shares Sold

CABA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 21, 2026	Buy	8,810	$2.27	$20.0K	5,405
Oct 18, 2022	Buy	1,000	$0.99	$993.50	0

Related Insiders

Gwendolyn Binder

President, Science & Tech.

CABABuy · Jan 21, 2026

David J. Chang

Chief Medical Officer

CABABuy · Jan 21, 2026

Steve Gavel

officer: Chief Commercial Officer

CABABuy · Jan 21, 2026

Michael Gerard

officer: General Counsel

CABABuy · Jan 21, 2026

Steven Nichtberger

President & CEO

CABABuy · Jan 21, 2026

Mark Simon

Director

CABABuy · Jan 21, 2026

Shawn Tomasello

Director

CABABuy · Jan 21, 2026

Explore More Insider Trading Data

CABA Insider Trading Activity

View all insider trades at Cabaletta Bio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity